Your browser doesn't support javascript.
loading
Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study.
Onal, Cem; Oymak, Ezgi; Guler, Ozan Cem; Tilki, Burak; Yavas, Guler; Hurmuz, Pervin; Yavas, Cagdas; Ozyigit, Gokhan.
Affiliation
  • Onal C; Department of Radiation Oncology, Adana Dr. Turgut Noyan Research and Treatment Center, Baskent University Faculty of Medicine, 01120, Adana, Turkey. hcemonal@hotmail.com.
  • Oymak E; Division of Radiation Oncology, Iskenderun Gelisim Hospital, Hatay, Turkey. hcemonal@hotmail.com.
  • Guler OC; Department of Radiation Oncology, Baskent University Faculty of Medicine, Ankara, Turkey. hcemonal@hotmail.com.
  • Tilki B; Division of Radiation Oncology, Iskenderun Gelisim Hospital, Hatay, Turkey.
  • Yavas G; Department of Radiation Oncology, Adana Dr. Turgut Noyan Research and Treatment Center, Baskent University Faculty of Medicine, 01120, Adana, Turkey.
  • Hurmuz P; Department of Radiation Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Yavas C; Department of Radiation Oncology, Baskent University Faculty of Medicine, Ankara, Turkey.
  • Ozyigit G; Department of Radiation Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Strahlenther Onkol ; 199(5): 456-464, 2023 05.
Article in En | MEDLINE | ID: mdl-36450836

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Radiosurgery / Kidney Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Strahlenther Onkol Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Radiosurgery / Kidney Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Strahlenther Onkol Year: 2023 Document type: Article